Transcriptome-wide association study of circulating IgE levels identifies novel targets for asthma and allergic diseases.

Published
February 17, 2023
Journal
Frontiers in immunology
PICOID
565e57b4
DOI
Citations
3
Keywords
GCNT1, IgE, allergic diseases, asthma, gene expression, immunoglobulin, immunotherapy
Copyright
Copyright © 2023 Recto, Huan, Lee, Lee, Gereige, Yao, Hwang, Joehanes, Kelly, Lasky-Su, O’Connor and Levy.
Patients/Population/Participants

Framingham Heart Study

Intervention

whole-blood derived RNA

Comparison

17,873 mRNA gene-level transcripts

Outcome

circulating IgE levels

Abstract

P
I
C
O

Measurement of circulating immunoglobulin E (IgE) concentration is helpful for diagnosing and treating asthma and allergic diseases. Identifying gene expression signatures associated with IgE might elucidate novel pathways for IgE regulation. To this end, we performed a discovery transcriptome-wide association study to identify differentially expressed genes associated with circulating IgE levels in whole-blood derived RNA from 5,345 participants in the Framingham Heart Study across 17,873 mRNA gene-level transcripts. We identified 216 significant transcripts at a false discovery rate <0.05. We conducted replication using the meta-analysis of two independent external studies: the Childhood Asthma Management Program (n=610) and the Genetic Epidemiology of Asthma in Costa Rica Study (n=326); we then reversed the discovery and replication cohorts, which revealed 59 significant genes that replicated in both directions. Gene ontology analysis revealed that many of these genes were implicated in immune function pathways, including defense response, inflammatory response, and cytokine production. Mendelian randomization (MR) analysis revealed four genes (

Similar article map

CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.